Vol 5, No 21 (November 02, 2017): Annals of Translational Medicine

Original Article

Factors that influence blood loss and need for transfusion following total knee arthroplasty
Achilleas Boutsiadis, Ryan Jacob Reynolds, Mo Saffarini, Jean-Claude Panisset
Annals of Translational Medicine
 2017;
5
(21)
:418
(November 2017)
PDF Pages: 418 Full Text (10803) Open Access Get Permission
Calcitonin gene-related peptide: neuroendocrine communication between the pancreas, gut, and brain in regulation of blood glucose
Sayali A. Pendharkar, Monika Walia, Marie Drury, Maxim S. Petrov
Annals of Translational Medicine
 2017;
5
(21)
:419
(November 2017)
PDF Pages: 419 Full Text (3838) Open Access Get Permission

Review Article

Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials
Jing Hu, Shuo Liu, Weihong Liu, Huina Zhang, Jing Chen, Hongcai Shang
Annals of Translational Medicine
 2017;
5
(21)
:420
(November 2017)
PDF Pages: 420 Full Text (3807) Open Access Get Permission
An innovative robotic platform for magnetically-driven painless colonoscopy
Federico Bianchi, Gastone Ciuti, Anastasios Koulaouzidis, Alberto Arezzo, Danail Stoyanov, Sebastian Schostek, Calogero Maria Oddo, Arianna Menciassi, Paolo Dario
Annals of Translational Medicine
 2017;
5
(21)
:421
(November 2017)
PDF Pages: 421 Full Text (3880) Open Access Get Permission
A global perspective on capsule endoscopy
Tanja Nowak
Annals of Translational Medicine
 2017;
5
(21)
:422
(November 2017)
PDF Pages: 422 Full Text (4632) Open Access Get Permission

Case Report

Surgical treatment of synchronous multiple neuroendocrine lung tumours (case series): is more always better?
Jury Brandolini, Luca Bertolaccini, Alessandro Pardolesi, Piergiorgio Solli
Annals of Translational Medicine
 2017;
5
(21)
:423
(November 2017)
PDF Pages: 423 Full Text (2609) Open Access Get Permission

Editorial

EGFR mutation positive non-small cell lung cancer: can we identify predictors of benefit from immune checkpoint inhibitors
Ying Wang, Peter Ellis
Annals of Translational Medicine
 2017;
5
(21)
:424
(November 2017)
PDF Pages: 424 Full Text (2904) Open Access Get Permission
Eravacycline for treatment of complicated intra-abdominal infections: the fire is not ignited!
Patrick M. Honore, Herbert D. Spapen
Annals of Translational Medicine
 2017;
5
(21)
:425
(November 2017)
PDF Pages: 425 Full Text (3083) Open Access Get Permission
Radiotherapy treatment strategies for squamous cell carcinoma of the cervical oesophagus: moving toward better outcomes
Pierfrancesco Franco, Francesca Arcadipane, Paolo Strignano, Renato Romagnoli, Umberto Ricardi
Annals of Translational Medicine
 2017;
5
(21)
:426
(November 2017)
PDF Pages: 426 Full Text (1956) Open Access Get Permission
Treatment recommendations by clinicians in stage I non-small cell lung cancer: better work-up leads to less discussion
Jo Raskin, Annelies Janssens, Jan P. Van Meerbeeck
Annals of Translational Medicine
 2017;
5
(21)
:427
(November 2017)
PDF Pages: 427 Full Text (1931) Open Access Get Permission
Towards a comprehensive framework for cell-free DNA analysis: lessons from TRACERx
Bryan C. Ulrich, Nicolas Guibert
Annals of Translational Medicine
 2017;
5
(21)
:428
(November 2017)
PDF Pages: 428 Full Text (2633) Open Access Get Permission
Fasting and engineered diets as powerful tool in the medical practice: an old approach in the new era
Concetta Panebianco, Adele Potenza, Valerio Pazienza
Annals of Translational Medicine
 2017;
5
(21)
:429
(November 2017)
PDF Pages: 429 Full Text (3556) Open Access Get Permission
Remote home monitoring to identify and prevent diabetic foot ulceration
P. Andrew Crisologo, Lawrence A. Lavery
Annals of Translational Medicine
 2017;
5
(21)
:430
(November 2017)
PDF Pages: 430 Full Text (3332) Open Access Get Permission
The role of foot collateral vessels on angiosome-oriented revascularization
César Varela, Francisco Acín, Joaquin De Haro, Ignacio Michel
Annals of Translational Medicine
 2017;
5
(21)
:431
(November 2017)
PDF Pages: 431 Full Text (3882) Open Access Get Permission
Increased cancer-specific mortality in individuals developing mental disorders after cancer diagnosis: biomedical factors versus psychosocial support
Siran M. Koroukian, Martha Sajatovic
Annals of Translational Medicine
 2017;
5
(21)
:432
(November 2017)
PDF Pages: 432 Full Text (2046) Open Access Get Permission
Alectinib can replace crizotinib as standard first-line therapy for ALK-positive lung cancer
Takehiro Uemura, Toyoaki Hida
Annals of Translational Medicine
 2017;
5
(21)
:433
(November 2017)
PDF Pages: 433 Full Text (3545) Open Access Get Permission
Very early antiretroviral therapy permits CD8 T cells to keep HIV reservoirs at bay
Jean-Pierre Routy, Vikram Mehraj
Annals of Translational Medicine
 2017;
5
(21)
:434
(November 2017)
PDF Pages: 434 Full Text (3867) Open Access Get Permission

Viewpoint

The evidence system of traditional Chinese medicine based on the Grades of Recommendations Assessment, Development and Evaluation framework
Hao Chen, Yan Wang, Wen-Bo Jiang, Joey S. W. Kwong, Yi-Huang Gu
Annals of Translational Medicine
 2017;
5
(21)
:435
(November 2017)
PDF Pages: 435 Full Text (3268) Open Access Get Permission

Big-data Clinical Trial Column1

Development of scoring system for risk stratification in clinical medicine: a step-by-step tutorial
Zhongheng Zhang, Haoyang Zhang, Mahesh Kumar Khanal
Annals of Translational Medicine
 2017;
5
(21)
:436
(November 2017)
PDF Pages: 436 Full Text (21863) Open Access Get Permission

Meet the Professor2

Treating our patients with compassion & respect: interview with Dr. Zhaolin Lu of the Department of Endocrinology of Peking Union Medical College Hospital
Lili Liao, Han Zhang
Annals of Translational Medicine
 2017;
5
(21)
:437
(November 2017)
PDF Pages: 437 Full Text (1968) Open Access Get Permission

Letter to the Editor

Pareidolias in idiopathic RBD—an author response letter to the Editorial “What the ‘man in the moon’ can tell us about the future of our brains”
Taeko Sasai-Sakuma
Annals of Translational Medicine
 2017;
5
(21)
:438
(November 2017)
PDF Pages: 438 Full Text (2430) Open Access Get Permission
Challenges to interpreting patient reported outcomes in clinical trials: author rejoinder
Melanie L. Bell
Annals of Translational Medicine
 2017;
5
(21)
:439
(November 2017)
PDF Pages: 439 Full Text (3508) Open Access Get Permission
Morbidity, mortality, and obesity paradox
Michael Spartalis, Eleni Tzatzaki, Demetrios Moris, Antonios Athanasiou, Eleftherios Spartalis
Annals of Translational Medicine
 2017;
5
(21)
:440
(November 2017)
PDF Pages: 440 Full Text (2033) Open Access Get Permission
Comment on “Mobile phone radiofrequency exposure has no effect on DNA double strand breaks (DSB) in human lymphocytes”
S. M. Javad Mortazavi
Annals of Translational Medicine
 2017;
5
(21)
:441
(November 2017)
PDF Pages: 441 Full Text (1817) Open Access Get Permission

Disclosure:

1. The series “Big-data Clinical Trial Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.

2. The series “Meet the Professor” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.